The size of the Single-Cell Analysis Market in North America was worth USD 0.83 billion in 2021 and estimated to be growing at a CAGR of 15.89% to reach USD 1.74 billion by 2026.
The genetic, functional, and compositional heterogeneity of tissues presents a significant challenge in research and development in the healthcare segment. The heterogeneity observed makes it impossible to design an accurate model that caters to all the needs. It is where single-cell analysis comes in. The complex nature of the heterogeneous tissues has led to the development of tools for single-cell genomic, transcriptomic, and proteomic analyses, which collectively is called single-cell analysis.
Further research today in the field of single-cell analysis has helped biologists to learn about gene expression profiles in cells and also reduced errors in research that would otherwise occur as a result of biologists taking averages in a heterogeneous population. Additionally, the continuous and rapid development in the field of single-cell analysis has opened up new avenues in research and led to the development of new technologies, application areas, and consumables.
The North American single-cell analysis market is driven by the emerging application of single-cell analysis in drug discovery. As the frequency of infectious diseases increases, there is a growing need to make drug discovery and development more efficient and faster. The single-cell analysis helps in this regard by overcoming the significant challenges of drug development and its associated research. Other drivers include the growing geriatric population and the rising demand for personalized medicine. As for the restraints of the market, the high prices associated with single-cell analysis is the main factor along with the stringent government regulations regarding the single-cell analysis.
This research report has been segmented and sub-segmented into the following categories:
Regional Analysis
The United States dominated the North American single-cell analysis market in 2019. The USA congress has the aim to introduce the latest innovations in single-cell transcription, genomics, and availability of next-generation techniques in the market. The presence of major industries engaged in creating highly innovative technologies with robust funding agencies in the U.S. has contributed growth in the single-cell analysis market in this country. Besides, the development in modern therapeutics such as IVF and parenteral screening is driving the growth of the US market. Recently, the high demands of single-cell analysis to identify Covid-19 RNA of infectious respiratory disease.
Canada's single-cell analysis market is driven by the high prevalence of chronic diseases and infectious diseases in the country. Moreover, personalized medicine treatment has contributed to high growth in Canada. Due to COVID-19 U.S. government provided more funding to develop single-cell analysis in this pandemic situation that can help to reduce the number of deaths. Additionally, the introduction of the single-cell uses convex lens microscopy for drug discovery and development. It will boost the single-cell analysis market in upcoming years. Also, more deaths of cancer patients every year are propelling the growth of the market.
Some of the Prominent Companies leading the North America Single-Cell Analysis Market Profiled in the Report are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Cell
5.1.1 Introduction
5.1.2 Human Cells
5.1.3 Animal Cells
5.1.4 Microbial Cells
5.1.5 Y-o-Y Growth Analysis, By Cell
5.1.6 Market Attractiveness Analysis, By Cell
5.1.7 Market Share Analysis, By Cell
5.2 Products
5.2.1 Introduction
5.2.2 Consumables
5.2.3 Instruments
5.2.4 Y-o-Y Growth Analysis, By Products
5.2.5 Market Attractiveness Analysis, By Products
5.2.6 Market Share Analysis, By Products
5.3 Techniques
5.3.1 Introduction
5.3.2 Flow Cytometry
5.3.3 NGS
5.3.4 PCR
5.3.5 Microscopy
5.3.6 Mass Spectrometry
5.3.7 Other Techniquess
5.3.8 Y-o-Y Growth Analysis, By Techniques
5.3.9 Market Attractiveness Analysis, By Techniques
5.3.10 Market Share Analysis, By Techniques
5.4 Applications
5.4.1 Introduction
5.4.2 Research Application
5.4.3 Medical Application
5.4.4 Y-o-Y Growth Analysis, By Applications
5.4.5 Market Attractiveness Analysis, By Applications
5.4.6 Market Share Analysis, By Applications
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Cell
6.1.3.3 By Products
6.1.3.4 By Techniques
6.1.3.5 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Cell
6.1.4.3 By Products
6.1.4.4 By Techniques
6.1.4.5 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Cell
6.1.5.3 By Products
6.1.5.4 By Techniques
6.1.5.5 By Application
6.2 United States
6.3 Canada
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five Analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Danaher Corporation
8.1.1 Overview
8.1.2 Cell Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA
8.3 Becton
8.4 Dickinson and Company
8.5 Promega Corporation
8.6 General Electric Company
8.7 Thermo Fisher Scientific
8.8 Miltenyi Biotec
8.9 Illumina
8.10 Bio-Rad Laboratories
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
